on 19 Feb 2024
Last Applicant/ Owned by
AMUNIX PHARMACEUTICALS INC.
2 Tower Pl Ste 1100South San Francisco, CA 94080
US
Serial Number
2174260 filed on 22nd Mar 2022
Registration Number
TMA1222417 registered on 19th Feb 2024
Registration expiry Date
19th Feb 2034Correspondent Address
33 Yonge Street, Suite 300Toronto
ONTARIO
CA
M5E1G4
Trademark usage description
biomedical compounds, namely, polypeptides for providing half-life extension; biomedical compounds, namely, polypeptides for universal masking of prot Read More12
12
2174260
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 190 on 19th Feb 2024 | Registration Pending |
Submitted for opposition 55 on 19th Feb 2024 | Registered |
Submitted for opposition 42 on 29th Nov 2023 | Advertised |
Submitted for opposition 27 on 02th Nov 2023 | Approval Notice Sent |
Submitted for opposition 26 on 02th Nov 2023 | Approved |
Submitted for opposition 22 on 27th Oct 2023 | Search Recorded |
Submitted for opposition 287 on 18th Jul 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 30 on 22nd Mar 2022 | Filed |
Submitted for opposition 1 on 22nd Mar 2022 | Created |
Submitted for opposition 31 on 22nd Mar 2022 | Formalized |